These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 3856477)
1. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477 [TBL] [Abstract][Full Text] [Related]
2. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
3. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
4. Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cells. Mini E; Srimatkandada S; Medina WD; Moroson BA; Carman MD; Bertino JR Cancer Res; 1985 Jan; 45(1):317-24. PubMed ID: 3855283 [TBL] [Abstract][Full Text] [Related]
5. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells. Miyachi H; Jiao L; Sowers LC; Scanlon KJ In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729 [TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells]. Sakai K Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines. Mini E; Moroson BA; Franco CT; Bertino JR Cancer Res; 1985 Jan; 45(1):325-30. PubMed ID: 3855284 [TBL] [Abstract][Full Text] [Related]
8. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase. Volpato JP; Fossati E; Pelletier JN J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689 [TBL] [Abstract][Full Text] [Related]
9. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II). Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492 [TBL] [Abstract][Full Text] [Related]
10. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968 [TBL] [Abstract][Full Text] [Related]
11. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy. Domin BA; Grill SP; Cheng Y Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441 [TBL] [Abstract][Full Text] [Related]
12. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells. Domin BA; Grill SP; Bastow KF; Cheng YC Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148 [TBL] [Abstract][Full Text] [Related]
13. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626 [TBL] [Abstract][Full Text] [Related]
14. Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. Pizzorno G; Mini E; Coronnello M; McGuire JJ; Moroson BA; Cashmore AR; Dreyer RN; Lin JT; Mazzei T; Periti P Cancer Res; 1988 Apr; 48(8):2149-55. PubMed ID: 2450647 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
16. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes. Urlaub G; Landzberg M; Chasin LA Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140 [TBL] [Abstract][Full Text] [Related]
17. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. Chu BC; Fan CC; Howell SB J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452 [TBL] [Abstract][Full Text] [Related]
18. Allelic variation in the dihydrofolate reductase gene at amino acid position 95 contributes to antifolate resistance in Chinese hamster cells. Yu M; Melera PW Cancer Res; 1993 Dec; 53(24):6031-5. PubMed ID: 8261418 [TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
20. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate. Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]